Martin, L., Alibhai, S., Komisarenko, M., Timilshina, N. and Finelli, A. (2018) “Identification of subgroups of metastatic castrate-resistant prostate cancer (mCRPC) patients treated with abiraterone plus prednisone at low- vs. high-risk of radiographic progression: An analysis of COU-AA-302”, Canadian Urological Association Journal, 13(6). doi: 10.5489/cuaj.5586.